Clinical Trial Update: Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of psilocybin in adults with treatment-resistant major depressive disorder has completed, reporting results fro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Treatment-resistant Depression | Phase 2 | Status: COMPLETED